fluoxetine and 6-nitroquipazine

fluoxetine has been researched along with 6-nitroquipazine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chi, DY; Choe, YS; Chu, S; Jeong, KJ; Jin, C; Lee, BC; Lee, BS1
Chu, S; Jin, C; Lee, BS; Se Lee, B; Song, YS; Yoon Chi, D1
Chi, DY; Choi, YH; Jin, C; Lee, BS; Lee, JH; Lim, YJ1
Abdul, M; Hoosein, NM; Logothetis, CJ1
Kaneko, S; Kawata, Y; Kondo, T; Mizuno, K; Murakami, T; Okada, M; Wada, K1

Other Studies

5 other study(ies) available for fluoxetine and 6-nitroquipazine

ArticleYear
Syntheses and binding affinities of 6-nitroquipazine analogues for serotonin transporter. Part 1.
    Bioorganic & medicinal chemistry letters, 2000, Jul-17, Volume: 10, Issue:14

    Topics: Animals; Binding, Competitive; Carrier Proteins; Cell Membrane; Cerebral Cortex; Citalopram; Drug Design; Indicators and Reagents; Kinetics; Membrane Glycoproteins; Membrane Transport Proteins; Models, Structural; Molecular Conformation; Nerve Tissue Proteins; Quipazine; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship

2000
Syntheses and binding affinities of 6-nitroquipazine analogues for serotonin transporter. Part 2: 4-substituted 6-nitroquipazines.
    Bioorganic & medicinal chemistry letters, 2002, Mar-11, Volume: 12, Issue:5

    Topics: Animals; Binding, Competitive; Carrier Proteins; Cerebral Cortex; Citalopram; Drug Design; Fluoxetine; Inhibitory Concentration 50; Kinetics; Male; Membrane Glycoproteins; Membrane Transport Proteins; Models, Structural; Nerve Tissue Proteins; Paroxetine; Quipazine; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship

2002
Syntheses and binding affinities of 6-nitroquipazine analogues for serotonin transporter. Part 5: 2'-Substituted 6-nitroquipazines.
    Bioorganic & medicinal chemistry, 2007, May-15, Volume: 15, Issue:10

    Topics: Animals; Chromatography, Thin Layer; In Vitro Techniques; Indicators and Reagents; Male; Mass Spectrometry; Piperazine; Piperazines; Quipazine; Rats; Rats, Sprague-Dawley; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship; Synaptic Membranes

2007
Growth-inhibitory effects of serotonin uptake inhibitors on human prostate carcinoma cell lines.
    The Journal of urology, 1995, Volume: 154, Issue:1

    Topics: Animals; Carcinoma; Cell Division; Dose-Response Relationship, Drug; Fluoxetine; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Mice, Nude; Neoplasm Transplantation; Prostatic Neoplasms; Quipazine; Selective Serotonin Reuptake Inhibitors; Soft Tissue Neoplasms; Transplantation, Heterologous; Tumor Cells, Cultured; Zimeldine

1995
Differential effects of adenosine receptor subtypes on release and reuptake of hippocampal serotonin.
    The European journal of neuroscience, 1999, Volume: 11, Issue:1

    Topics: Adenosine; Animals; Antihypertensive Agents; Biological Transport; Caffeine; Central Nervous System Stimulants; Fluoxetine; Hippocampus; Male; Microdialysis; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quipazine; Rats; Rats, Wistar; Receptor, Adenosine A2A; Receptor, Adenosine A3; Receptors, Purinergic P1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Theobromine; Theophylline; Vasodilator Agents

1999